Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Ophthalmic Drugs Market?

In recent times, there has been robust growth in the ophthalmic drugs market. The market worth was $39.36 billion in 2024 and it is projected to rise to $42.65 billion in 2025, with an impressive compound annual growth rate (CAGR) of 8.3%. The unprecedented growth during the historic period is due to factors such as a rise in the number of eye disorder cases, investment in research and development for eye care, shifts in lifestyle, a worldwide increase in diabetes instances, and governmental efforts towards vision care.

What Growth Rate Is Forecasted for the Ophthalmic Drugs Market by 2029?

In the forthcoming years, the ophthalmic drugs market is predicted to witness a substantial surge. The market size is forecasted to soar to “$57.4 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%. This expected increment during the forecast duration can be attributed to the innovations in biopharmaceutical, growing cases of myopia, the rapidly aging population, advancement in personalized medicine, and the regulatory support available for rare diseases. Some of the upcoming trends within this period include biological and gene therapies, heightened concentration on dry eye treatments, progression in treating glaucoma, the rise of combination therapies, and emphasizing age-related macular degeneration (AMD).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10065&type=smp

Which Key Companies Are Shaping the Future of the Ophthalmic Drugs Market?

Major companies operating in the ophthalmic drugs market include AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Coherus Biosciences Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Mitotech SA, Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Xbrane Biopharma AB, Laboratoires Théa

Which Factors Are Driving Demand in the Ophthalmic Drugs Industry?

The escalating occurrence of eye-related disorders is predicted to spark an upswing in the ophthalmic drug market. These disorders, encompassing any disease or disturbance that impacts the eye and its related parts, often result in compromised vision and various other eye diseases. Pharmaceutical medications known as ophthalmic drugs are utilized to combat these diseases that impair vision or eye health. Consequently, the escalating occurrence of eye-related disorders boosts the demand for the ophthalmic drug market. To illustrate, in 2022, the Centers for Disease Control and Prevention (CDC), a government agency in the US, indicated that 17.2% of Americans over 40 years of age, or about 20.5 million people, will suffer from a cataract in at least one eye. Therefore, the escalating occurrence of eye-related disorders is fuelling the growth of the ophthalmic drug market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10065&type=smp

How Is the Ophthalmic Drugs Market Segmented by Several Divisions?

The ophthalmic drugs market covered in this report is segmented –

1) By Type: Prescription Drugs, Over-The-Counter Drugs

2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes

3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases

4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems

5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Prescription Drugs: Antiglaucoma Agents, Anti-inflammatory Drugs, Antibiotics, Antivirals, Corticosteroids, Other Prescription Drugs

2) By Over-The-Counter Drugs: Artificial Tears, Allergy Relief Medications, Redness Relievers, Ocular Vitamins And Supplements, Other OTC Drugs

What are the Emerging Market Trends Driving the Growth of the Ophthalmic Drugs Industry?

One significant trend gaining traction in the ophthalmic drug market is product innovation. The leading companies in this industry are focused on creating innovative solutions to solidify their market position. For example, in January 2022, Sun Pharmaceutical Canada Inc., a Canada-based company specializing in the research and development of advanced medicines in dermatology and ophthalmology, introduced an ophthalmic drug called CEQUA (cyclosporine ophthalmic solution 0.09% w/v) to treat dry eye disease in Canada. The drug uses nano micellar (NCELL) technology, which enhances ocular tissue penetration by augmenting the bioavailability and physicochemical stability of cyclosporine.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

Which Regions Are Driving Growth in the Ophthalmic Drugs Market?

North America was the largest region in the ophthalmic drugs market in 2024. The regions covered in the ophthalmic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10065

This Report Delivers Insight On:

1. How big is the ophthalmic drugs market, and how is it changing globally?

2. Who are the major companies in the ophthalmic drugs market, and how are they performing?

3. What are the key opportunities and risks in the ophthalmic drugs market right now?

4. Which products or customer segments are growing the most in the ophthalmic drugs market?

5. What factors are helping or slowing down the growth of the ophthalmic drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model